Unveiling the Prevalence of Charcot Foot in Diabetes Patients: A Comprehensive Swedish Study #ActAgainstAmputation #Charcot

Introduction: Charcot foot (CF), a significant complication in diabetic patients with distal peripheral neuropathy, has had its incidence and prevalence widely debated. A groundbreaking Swedish study, published in Diabetes Care (December 2023), now provides a comprehensive nationwide perspective. Study Overview: Spanning from 2001 to 2016, the study utilized three key Swedish registries to identify CF... Continue Reading →

Disparities that Cut Deep: Understanding the Social Determinants Behind Amputation Rates in the US #DiabetesAwarenessMonth #ActAgainstAmputation #ALPSlimb #HealthDisparities #SocioeconomicFactors #HealthcareAccess #SDOH

The Intersection of Health Equity and Limb Preservation The recent study by Kassavin et al., published in 2023, illuminates a critical public health issue: the varying rates of amputations across different communities and the underlying social factors that contribute to these disparities. #AmputationPrevention #SocialDeterminantsOfHealth #PublicHealth #LimbSalvage Disparities That Cut Deep The research found that counties... Continue Reading →

What’s the prevalence of prediabetes, worldwide? @DiabetesCareADA

Click above for superb data from Rooney and coworkers. OBJECTIVE To estimate the global, regional, and national prevalence of prediabetes, defined by impaired glucose tolerance (IGT) or impaired fasting glucose (IFG). RESEARCH DESIGN AND METHODS We reviewed 7,014 publications for high-quality estimates of IGT (2-h glucose, 7.8–11.0 mmol/L [140–199 mg/dL]) and IFG (fasting glucose, 6.1–6.9... Continue Reading →

Journal of the American Medical Association: Diabetic Foot Ulcers @JAMA_Current #ActAgainstAmputation #DiabeticFoot

From JAMA Armstrong, Tan, Boulton, and Bus, JAMA. 2023;330(1):62-75. doi:10.1001/jama.2023.10578 In diabetic foot disease, tissue loss,ischemia, and infection frequentlyoverlap. However, one is frequentlymore dominant than the other atdifferent times in the life cycle of anacute-on-chronic event. Here, theamount of tissue loss, ischemia, andfoot infection can be ordinally gradedto help predict outcome and assist incommunicating a plan... Continue Reading →

New Study Reveals Racial Disparities in Treatment and Outcomes for Patients with Peripheral Artery Disease ActAgainstAmputation #DiabeticFoot @ALPSlimb @USC @USC_vascular @ResearchatUSC @KeckSchool_USC

FOR IMMEDIATE RELEASE New Study Reveals Racial Disparities in Treatment and Outcomes for Patients with Peripheral Artery Disease Los Angeles, CA - March 10, 2023 - Researchers at the University of Southern California (USC) have published a new study in the journal Advanced Therapeutics revealing significant disparities in the treatment and outcomes for patients with... Continue Reading →

Sex differences in diabetic foot ulcer severity and outcome #ActAgainstAmputation @ALPSlimb #Belgium @PLoSOne #Location

We thank our Belgian colleagues for this enormously useful data. Bottom line: Sex differences play an important role in the epidemiology, treatment, and outcomes of many diseases. Men with diabetic foot ulcers (DFU) presented with more severe ulcers and had a higher prevalence of previous lower limb revascularization and smoking compared to women. Women with... Continue Reading →

Etiology, Epidemiology, and Disparities in the Burden of Diabetic Foot Ulcers #ActAgainstAmputation @ALPSLimb @CaitlynWHicks @DiabetesCareADA

An important and comprehensive review from McDermott and coworkers at JHU and Prof. Boulton at Manchester. Diabetic foot ulcers (DFU) are a major source of preventable morbidity in adults with diabetes. Consequences of foot ulcers include decline in functional status, infection, hospitalization, lower-extremity amputation, and death. The lifetime risk of foot ulcer is 19% to... Continue Reading →

Cost of Treatment of Neuroischemic Ulcers of the Lower Extremity in Patients with Peripheral Artery Disease in the United States ActAgainstAmputation #DiabeticFoot @ALPSlimb @USC @USC_vascular @ResearchatUSC @KeckSchool_USC @JAPMAFeetTweets @APMA

This from our team USC and colleagues Paul Saatsoglou and Susan Pitman-Lowenthal. Bottom line: This study analyzed the cost of treating neuroischemic ulcers (a type of wound) on the lower extremities in patients with peripheral artery disease using medical and hospital claims records submitted for reimbursement to private insurance, Medicare, and Medicaid. The study population... Continue Reading →

Global estimates of diabetes-related amputations incidence in 2010 to 2020: A systematic review and meta-analysis #ActAgainstAmputation @ALPSlimb #DiabeticFoot

Global estimates of diabetes-related amputations incidence in 2010–2020: A systematic review and meta-analysis Great work from our Valencia and Pamplona Global estimates of diabetes-related amputations incidence in 2010–2020: A systematic review and meta-analysis Global estimates of diabetes-related amputations incidence in 2010–2020: A systematic review and meta-analysis Yasmin Ezzatvara, Antonio García-Hermoso Aims/hypothesis: This study sought to... Continue Reading →

Association of Race, Ethnicity, and Rurality With Major Leg Amputation or Death Among Medicare Beneficiaries Hospitalized With Diabetic Foot Ulcers @ALPSlimb #ActAgainstAmputation

A superb manuscript from Meghan Brennan and coworkers from Wisconsin. This so clearly shows the overlap of socioeconomic status, rurality, and ethnicity. Key Points Question  Is the intersection of race, ethnicity, rurality, and/or neighborhood disadvantage associated with outcomes among US patients with diabetic foot ulcers? Findings  In this cohort study of 124 487 patients hospitalized with diabetic foot... Continue Reading →

Up ↑

%d
Verified by MonsterInsights